MedTrace Logo

Real Time In-Vivo Body Surface Dosimetry for External Beam Radiation Therapy

NCT02407977 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2018-10-22

No results posted yet for this study

Summary

This is an observational study. This protocol will determine the feasibility of using a novel nano-material based fiber-optic dosimeter (nanoFOD) device, with dimensions less than 1 mm wide, to measure real-time, pin-point, in-vivo radiation dose given during external beam delivery of radiation therapy treatments.This new protocol is similiar in design to Pro00050297 with the significant difference being the monitoring will be performed during external baem radiotherapy.

Conditions

  • Cancer of the Gastrointestinal, Genitourinary or Gynecologic Systems

Interventions

OTHER

Novel nano-scintillatorfiber-optic dosimeter ( nanoFOD)

This is an observational study whose purpose is to determine the feasibility of using a novel nano-scintillator fiber-optic dosimeter ( nanoFOD) for real time dosimetric monitoring of external beam radiotherapy.

Sponsors & Collaborators

  • Wallace H. Coulter Foundation

    collaborator OTHER

  • Duke University

    lead OTHER

Principal Investigators

  • Junzo Chino, MD · Duke Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-13
Primary Completion
2017-04-19
Completion
2017-04-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02407977 on ClinicalTrials.gov